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Mission Statement 
 
The Marine Institute is the national agency which has the following functions: 
‘to undertake, to coordinate, to promote and to assist in marine research and development 
and to provide services related to marine research and development, that in the opinion of the 
Marine Institute will promote economic development and create employment and protect the 
environment’ 
Marine Institute Act 1991 
 
Our Vision 
 
A thriving maritime economy in harmony with the ecosystem and supported by the 
delivery of excellence in our services. 
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Summary 
 
The Marine Institute carries out monitoring of chemical residues in aquaculture in 
accordance with Council Directive 96/23/EC of 29 April 1996, on measures to monitor 
certain substances and residues thereof in animals and animal products, also known as the 
Residues Directive. This is carried out on behalf of the Department of Agriculture, Food 
and the Marine (DAFM). For the aquaculture sector, the Sea Fisheries Protection 
Authority (SFPA) with technical support from the Institute is responsible for residue 
controls on farmed finfish on behalf of the national residue monitoring plan.  Annually, 
the National Residues Control Plan (NRCP) for Aquaculture is prepared by the 
Institute and this sets out the monitoring requirements for residues in animal products 
in required by the directive.  The main objectives of the National Residue Control Plan 
for Aquaculture is to ensure farmed fish are fit for human consumption; to provide a 
body of data showing that Irish farmed fish is of high quality; to promote good 
practices in aquaculture;  and to comply with EU Directive 96/23/EC.   
 
Based on production tonnage, the following species for the period of 2012 to 2014 
were sampled and tested: Atlantic salmon (Salmo salar), freshwater and sea reared 
trout (Oncorhynchus mykiss & Salmo trutta). In excess of 2,141 tests and a total of 4,972 
residue measurements were carried out over this three year period. Tests were 
carried out for banned substances such as growth promoters and other unauthorised 
substances such as malachite green, which should not be present. Harvest fish were 
also tested for authorised veterinary treatments such as antibiotics and sea lice 
treatments, environmental contaminants such as trace metals, polychlorinated 
biphenyls and organochlorine pesticides, to check for compliance with Maximum 
Residue Levels (MRL) where available. 
 
As in previous years, no non-compliant results were reported in the surveillance 
monitoring programme for farmed finfish during the period 2012 to 2014. Overall, in 
recent years the outcome for aquaculture remains one of consistently low occurrence 
of residues in farmed finfish, with 0.23% non-compliant results from routine targeted 
monitoring in 2004, 0.09% in 2005 and one of full compliance with 0% non-
compliant target residue results for the period 2006-2014. 
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1.0 BACKGROUND 
 
All European Member States have a responsibility to monitor the use of veterinary 
medicines in food producing animals, to ensure that produce from these animals do not 
contain residues that could be harmful to consumers. Surveillance monitoring is 
implemented in accordance with Council Directive 96/23/EC of 29 April 1996, on measures 
to monitor certain substances and residues thereof in animals and animal products, otherwise 
known as the Residues Directive, which requires Member States to put in place national 
plans (National Residues Control Plan - NRCP) for the monitoring of certain chemical 
substances and residues in a range of food producing species and products e.g. cattle, pigs, 
sheep, farmed finfish.  
 
The Marine Institute monitors aquaculture finfish for the presence of chemical residues in 
accordance with Council Directive 96/23/EC on behalf of Department of Agriculture Food 
and Marine (DAFM). For the aquaculture sector, the Sea Fisheries Protection Authority 
(SFPA) with technical support from the Marine Institute is responsible for residue controls 
on farmed finfish on behalf of the national residue monitoring plan.  The NRCP for 
Aquaculture in Ireland is specifically for farmed finfish and forms part of the overall 
National Residue Control Plan. The main objectives of the NRCP for Aquaculture is to 
ensure farmed fish are fit for human consumption; to provide a body of data showing that 
Irish farmed fish is of high quality; to promote good practices in aquaculture and to comply 
with EU Directive 96/23/EC.  
 
2.0 IMPLEMENTING THE DIRECTIVE 
 
DAFM, SFPA, Food Safety Authority of Ireland (FSAI) and the Marine Institute implement 
the Directive as it pertains to aquaculture; outlined below is an overview of their roles for 
aquaculture and Table 1 gives a summary of each department and agencies’ role with 
respect to the NRCP for aquaculture: 
 
Figure 1: Agencies & Department involved in Residue Monitoring Programme for Aquaculture 
 
Department 
of 
Agriculture 
Food and the 
Marine  
Marine 
Institute 
Food Safety 
Authority of 
Ireland  
Sea Fisheries 
Protection 
Authorities  
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 Department of Agriculture Food and the Marine (DAFM) 
DAFM implements the overall residues controls in Ireland with the DAFM Veterinary 
Inspectors (VIs) who carry out routine inspections on finfish farms. These inspections are 
carried out to verify compliance with Fish Health, Animal Remedies, Feedstuffs, Animal-By 
Products and Food hygiene regulations. If an issue or non-compliance arises from a routine 
inspection, DAFM VIs will conduct a follow-up investigation. Assistance may be required 
from the Marine Institute with respect to sampling and analysis and from the SFPA in 
closing out the follow-up. 
 
 Food Safety Authority of Ireland 
The Food Safety Authority of Ireland co-ordinates the activities of the various departments 
and agencies involved in delivering this programme.  
  
Table 1: Department and Agencies Roles 
 
Department of Agriculture Food and the Marine  
Implements the overall residues controls in 
Ireland 
Food Safety Authority of  Ireland  
Coordinates the activities of the departments and 
agencies involved 
Sea Fisheries Protection Authority  
Responsible for ensuring compliance with the 
Directive for finfish aquaculture 
Marine Institute  
Implements the surveillance monitoring 
programme for farmed fish. Is the official 
laboratory for residue sampling and analysis and is 
the national reference laboratory (NRC) for a 
number of substances in Aquaculture 
DAFM Veterinary Inspectors 
Carry out routine on-farm inspections to verify 
compliance with various regulations including fish 
health, animal remedies, feedstuffs etc.  
 
 
 Sea Fisheries Protection Authority (SFPA) 
SFPA is responsible for ensuring compliance with the Residues Directive for Finfish 
Aquaculture and for the follow-up of samples that are non-compliant under the NRCP. If a 
non-compliant result were to arise from sampling under the NRCP the SFPA will carry out 
a follow-up investigation with the assistance of the Marine Institute to carry out sampling 
and analysis. Assistance may be required from DAFM VIs in closing out the follow-up 
investigation. 
 
 Marine Institute 
The Marine Institute is the official laboratory for residue sampling and analysis of farmed 
finfish under the NRCP. The Institute aids and assists the SFPA in follow-up investigations 
and provides scientific advice as required. Marine Institute officers are authorised under 
Section 10(1) of the Animal Remedies Act, 1993. The Institute is also a National Reference 
Laboratory (NRL) for certain substances under the overall NRCP (see section 8.3). 
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3.0 THE NRCP FOR AQUACULTURE 
 
Annually, the Marine Institute prepares the NRCP for Aquaculture1, which is reviewed and 
finalised by SFPA, FSAI and DAFM. This sets out the species, sample numbers, target 
substances and analytical methods in line with the specific requirements of Directive 
96/23/EC.  The NRCP once agreed is then submitted to the European Commission (EC) 
for approval.  Figure 2, details the Annual Cycle of National Residue Control Programme 
for Aquaculture. 
 
The national legal basis for the Residue Monitoring Plan is provided for in the Animal 
Remedies Act, 1993 and other relevant legislation in particular, the Control of Animal 
Remedies and their Residues Regulations, 2009. For further details of the main legislation 
and monitoring of the Irish finfish aquaculture industry reference the legislation section of 
this document. 
 
As with other farmed animals, farmed finfish can be subject to disease and infestation which 
can have animal welfare, environmental and commercial implications. The scope of this 
testing under the NRCP is comprehensive covering the following broad categories outlined 
in Table 2.  
 
Table 2: NRCP testing categories 
                                                 
1 Reference Appendix 3 for 2012, 2013 & 2014 NRCP for Finfish 
 
Category  Details  
Banned  These compounds should not be present as no safe limit can be set for their 
residue 
e.g. steroids, chloramphenicol, nitroimidazoles  
Authorised  Authorised medicines which may be used in aquaculture and should be below 
statutory limit (i.e. Maximum Residue Limit – MRL*)  
e.g. Sea lice treatments- emamectin, deltamethrin  
Unauthorised  These compounds should not be present as these treatments should not be used 
in aquaculture. e.g. malachite green  
Environmental 
contaminants  
Certain contaminants can be introduced inadvertently which may accumulate in 
fish  
e.g. polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs), heavy 
metals  
*MRL is the maximum concentration allowable in the edible portion of the animal which should not be exceeded at the time of harvest. 
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The substances are classed into two categories: Group A and Group B 
 
Group A: 
Group A substances are banned substances and should not be present in farmed 
finfish. These can be categorised as the following: 
 A3 Steroids such as  beta-oestradiol and methyltestosterone which occur naturally 
but also could be used for growth promotion 
 A6 compounds such as nitrofurans and nitroimidazole which are antibacterial 
drugs; chloramphenicol which has a broad spectrum of antibiotic properties 
A Maximum Residue Limits (MRL) cannot be established for these substances because 
of their toxicity; therefore, these substances are banned and should not be detected. 
 
Group B: 
Group B substances are classed into three categories: unauthorised substances, 
authorised substances and environmental contaminants. As with other 
intensively farmed animals farmed finfish can be subject to disease and infestation 
which can have animal welfare, environmental and commercial implications. Similar 
procedures are in place for the treatment of farmed finfish as for other farmed animals,  
with approved veterinary medicines administered under the direction of a veterinarian. 
These include antibiotics and anthelminthics to prevent or treat disease or infestation 
e.g. antibacterial agents, antifungal agents, antiparasitic treatments. To ensure 
compliance with Maximum Residue Limits (MRLs), operators are obliged to adhere to 
the specified withdrawal periods after treatment before harvesting. 
 
In terms of environmental contaminates, fish including farmed finfish, can accumulate 
trace metals and persistent organic pollutants (POPs) from the environment or the 
feed. Seafood can be an important contributor to the dietary intake of POPs and 
mercury; therefore these contaminants are also examined. For further details on 
environmental contaminants see section 6.0. 
 
Details are given in Table 3 of what group substances are tested for in the NRCP for 
aquaculture and a breakdown of the compounds that were tested for in the 2012 to 
2014 plan outlined in Table 4. 
Table 3: List of substances included in the NRCP for farmed finfish. 
Group A–Substances having anabolic effect , 
banned  
Group B- Veterinary drugs, unauthorised 
substances and contaminants 
A3 Steroids B1 Antimicrobials (Antibacterial) 
A6 Compounds included in Annex IV of 
Council Regulation 2377/90/EC 
B2a Anthelmintics (Antiparasitic) 
B2c Pyrethroids 
B2f Other pharmacologically active substances 
B3a Organochlorine compounds 
B3c Chemical elements 
B3d Mycotoxins 
B3e Dyes 
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Table 4: List of substances included in the 2012-2014 Residue plan for farmed finfish 
Group A–Substances having 
anabolic effect, banned 
Group B- Veterinary drugs, unauthorised substances and 
contaminants 
A3 Steroids:  
Methyltestosterone 
17 ß-Oestradiol 
 
B1 Antimicrobials 
(Antibacterial): 
Quinolones 
Tetracyclines 
Sulphonamides 
Florfenicol 
B3a Organochlorine 
compounds: 
PCBs 
OCPs 
A6 Compounds included in 
Annex IV of Council 
Regulation 2377/90/EC: 
Chloramphenicol 
Nitrofurans  
Nitroimidazoles  
B2a Anthelmintics 
(Antiparasitic): 
Ivermectin 
Emamectin B1a 
Doramectin* 
B3c Chemical elements: 
Lead 
Cadmium 
Mercury 
  B2c Pyrethroids: 
Cypermethrin 
Deltamethrin 
B3d Mycotoxins: 
Aflatoxin 
B2f Other pharmacologically 
active substances: 
Teflubenzuron 
Diflubenzuron 
Corticosteroids 
B3e Dyes: 
Malachite Green 
Leuco Malachite 
Green 
Crystal Violet* 
Leuco Crystal Violet* 
Brilliant Green* 
Victoria Blue* 
*2014 analysis only 
 
3.1 VETERINARY MEDICINES 
 
The overall national responsibility for the regulation of the veterinary medicines 
marketed in Ireland is with DAFM. The Health Products Regulatory Authority (HPRA), 
formerly known as Irish Medicines Board, is responsible for authorisation and licencing 
of animal remedies product.  In addition to the authorised product license, DAFM also 
implements an ‘exceptional’ licensing regime for the importation of animal remedies 
authorised in another Member State in ‘Certain Health Situations’; Regulation 16 S.I. 
786 of 2007 and under the ‘Cascade Provision’; Regulation18 S.I. 786 of 2007. The 
‘Cascade’, is an exceptional mechanism provided for in EU and National legislation. 
This is designed to deal with situations where there is no authorised product to treat a 
particular condition in an animal, the emphasis therefore is on avoiding unacceptable 
suffering in an animal.  
 
 
Some veterinary 
substances are 
used to control 
sea lice 
infestations of 
farmed salmon 
 
 
 
Figure 3: Sea 
lice on fish 
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A particular issue for the finfish aquaculture sector is the requirement to control ecto-
parasitic sea lice (Lepeophtheirus salmonis, Caligus elongatus) infestations on fish farms 
(Fig. 3). Sea lice levels are monitored on fish farms with a requirement to treat if 
trigger levels are exceeded; further information on results for sea lice inspections 
carried out by the Marine Institute in 2014 is available in O’Donohoe et al, 2015. 
Targeted treatment regimes can include synchronous treatments, i.e. “Single Bay 
Management”. Further information is available in: “A strategy for the improved pest 
control on Irish salmon farms” (DAFF, 2010), which outlines a comprehensive range of 
measures to provide for enhanced sea lice control and in “The Farmed Salmonid 
Health Handbook” (Marine Institute, 2011), which assists producers in establishing a 
framework which will protect animal health and promote fish welfare on Irish farms. 
Table 5 details the veterinary medicines that are available for use in Ireland in 2014 for 
farmed finfish. Note in 2007 the Marine Institute carried out a review on veterinary 
treatments and other substances in Finfish Aquaculture in Ireland for South Western 
River Basin District (Marine Institute, 2007).  
 
Table 5: Veterinary medicines authorised for use in Finfish 2014^ 
Medicine Active 
Ingredient 
Treatment Group Licensing Status 
AMX ® 
 
Deltamethrin Bath Pyrethroid Full Medical 
Authorisation 
Calicide ® Teflubenzuron In-Feed Insect Growth 
regulator 
Full Medical 
Authorisation 
Aqualet ® Oxytetracycline 
Hydrochloride 
In-Feed Antibiotic Full Medical 
Authorisation 
Maracycline ® Oxytetracycline 
Hydrochloride 
In-Feed Antibiotic Full Medical 
Authorisation 
Excis ® Cypermethrin Bath Pyrethroid Full Medical 
Authorisation 
Slice ® Emamectin 
Benzoate 
In-Feed Avermectin Full Medical 
Authorisation 
Pyceze ® Bronopol Bath used on 
eggs 
Antimicrobial Full Medical 
Authorisation 
Slice ® Emamectin 
Benzoate 
In-Feed Avermectin Full Medical 
Authorisation 
Paramove ® Hydrogen 
Peroxide 
Bath Oxidizer Full Medical 
Authorisation 
Florocol ® Florfenicol In-Feed Antibiotic Regulation18 ^^ 
^Further details on veterinary medicines reference report prepared by the Marine Institute for SWRBD March 2007 
^^Certain  veterinary  medicines  are  authorised  by  DAFM  in  accordance  with  the  provisions  of  national  legi
slation  (Regulations  16  &  18,  S.I.  No.  786 of 2007).  
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3.2 ENVIRONMENTAL CONTAMINANTS 
 
Farmed finfish can accumulate trace metals and persistent organic pollutants from their 
feed or the environment; therefore levels of these contaminants are examined in 
farmed finfish. 
 
 Trace metals  
Trace metals exist naturally in the environment and many, including chromium, copper, 
iron and zinc are essential elements for living organisms. Some trace metals such as 
mercury, lead and cadmium are not required for metabolic activity and can be toxic at 
quite low concentrations. These can also be introduced into the aquatic environment 
from activities such as mining, industry and municipal waste. Once in the aquatic 
environment these metals can be bioaccumulated. As part of the NRCP mercury, 
cadmium and lead are examined. Maximum levels for mercury, cadmium and lead in 
fisheries products are set out in Commission Regulation (EC) No 1881/2006 as 
amended setting maximum levels for certain contaminants in foodstuffs.  For salmon and 
trout the levels specified are 0.3 mg kg-1 for lead, 0.05 mg kg-1 for cadmium and 0.5 mg 
kg-1 for mercury.  These are taken as the “action levels” for the following report.  
 
 Persistent organic pollutants 
Persistent organic pollutants (POPs) are primarily anthropogenic toxic substances that 
are persistent in the environment. They can be transported long distances in air and 
water and consequently tend to be globally ubiquitous pollutants. They bioaccumulate 
in animal tissue, especially fatty tissues such as oily fish and may biomagnify through the 
food chain. Seafood is one of the key dietary sources for humans. Examples of POPs 
include polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs) such as 
DDT, dioxins, certain brominated flame retardants and perfluorinated compounds. 
Consequently POPs are widely monitored in seafood to ensure consumer safety. 
Measures to control or phase out POPs have been implemented at national, regional 
and global scales over recent decades (OSPAR 2010, EPA 2012) and environmental 
concentrations of many POPs are generally decreasing, although given their persistence 
this is a slow process. POPs are found in the tissue of farmed fish, primarily due to 
uptake from fish feed, and this is associated with the POP burdens in the wild fish 
oil/meal component of the feed (Berntssen et al. 2010).   
 
An assessment of contaminants and residues in Irish seafood (2004 -2008) was carried 
out by the Marine Institute (McGovern et al, 2011). This identified that Irish seafood 
(fish and shellfish) was compliant with standards. The report also determined that 
estimates of intake of mercury, hexachlorobenzene and dioxins and dioxin-like PCBs 
from seafood consumption for the average Irish adult seafood consumer accounted for 
less than one fifth of the individual (provisional) tolerable weekly intake ((p)TWIs)  as 
established by the European Food Safety Authority (EFSA) for these substances. 
Moreover, the report highlighted the well-established health benefits of eating fish, 
especially oily fish such as salmon, herring and mackerel. More information on POPs in 
Irish seafood, including farmed finfish, is available in McGovern et al, 2011 and in FSAI 
(2013) report which was carried out in conjunction with the Marine Institute in 2010-
2011 to survey a broad range of halogenated POPs in Irish fishery products. Six farmed 
salmon and two sea reared trout were included in this survey. 
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As part of the NRCP the following POPs are examined:  
 Polychlorinated Biphenyls (PCBs): 
PCBs are a group of homologous man-made substances with a molecular 
structure comprising of a chlorinated biphenyl ring. PCBs are used in a wide 
range of industrial applications due to their thermal and electrical insulation 
properties. Despite being banned since the 1980s they are still being found in 
long life equipment such as electrical transformers and capacitors (EPA 2012). 
They are persistent environmental contaminants that accumulate in lipids and as 
such can be present at levels of concern in fish. PCBs can be divided into groups 
according to their toxicological properties e.g. dioxin-like PCBs, non dioxin-like 
PCBs. As part of the NRCP, it is primarily the following six non dioxin-like PCBs 
(NDL-PCB) which are monitored; PCB 28, 52, 101, 138, 153 and 180. These 
NDL-PCBs are routinely used as a monitoring indicator as they are generally 
presumed to be the most persistent in fish tissue and comprise about half of the 
amount of total PCB present in feed and food. Recent European legislation 
(Commission Regulation (EU) No 1259/2011 which came into force 1st Jan 2012 
amending Regulation (EC) 1881/2006) has fixed maximum levels for dioxins, 
dioxin-like PCBs and non dioxin-like PCBs in foodstuffs. In the case of NDL- 
PCBs (also known as ICES PCB 6) the maximum level of 75 ug kg-1 wet weight 
has been set for the sum of these six congeners and samples analysed as part of 
the NRCP are consistently within these regulatory limits. 
 
 Organochlorine pesticides (OCPs): 
OCPs are synthetic substances used for pest control that are persistent and 
widespread in the marine environment, despite their use being progressively 
phased out in recent decades. Chlorinated pesticides behave similarly to PCBs in 
the environment and do not have maximum concentrations in fish set by the EC. 
Due to their chemical properties (fat solubility) these substances bio-accumulate 
in fish tissue and also bio-magnify through the marine food chain with high levels 
especially found in marine mammals. A number of OSPAR contracting countries 
have set levels and Table 11 shows the available standards/guidance values in so 
far as Marine Institute is aware of these. All the samples analysed for chlorinated 
pesticides as part of the NRCP were below these levels. 
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4.0 METHODOLOGY 
 
4.1 SAMPLING  
Residue sampling is carried out by Marine Institute authorised sampling officers 
(Authorised under the Animal Remedies Act 1993) in accordance with Council 
Directive 96/23/EC. The Institute ensures that sampling is unforeseen, unexpected, 
without prior warning and that a strict chain of custody is maintained in accordance 
with Article 3 of Regulation 882/2004; “Member States shall ensure that official controls 
are carried out regularly, on a risk basis and with appropriate frequency” and Article 12 of 
Council Directive 96/23/EC; “The checks provided for in this Directive must be carried out 
by the competent national authorities without prior notice”.  
 
 
Figure 4: The Residue Directive for Finfish aquaculture- Sampling process 
 
The following species were sampled and analysed as part of the NRCP for 2012 to 
2014 (Fig. 5): Atlantic salmon (Salmo salar), freshwater and sea reared trout 
(Oncorhynchus mykiss & Salmo trutta). Typically, five individual fish were collected 
per farm by a Marine Institute authorised officer from a producer at either the 
processing plant or fish farm. Each fish was taken as an individual sample, however 
where an individual fish was not large enough to provide sufficient test material, a 
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number of fish were pooled to provide a sample. Samples were further subsampled as 
multiple tests were typically performed on individual samples. 
 
 
Atlantic salmon (Salmo salar) 
 
 
 
Rainbow trout (Oncorhynchus mykiss) 
 
Brown Trout (Salmo trutta) 
 
Figure 5: 3 species sampled as part of NRCP 2012-2014 (BIM, 2015) 
 
Figure 6 shows the residues sampling lifecycle from a fish farmer’s perspective. Figure 
7-9 illustrates the locations of farmed finfish sites sampled in Ireland in 2012, 2013 and 
2014.  
 
Figure 6: Residues sampling life cycle 
 
 
 
 
 
Samples taken at fish 
farm/processing 
plant 
Samples 
analysed
Acknowledgement 
letter sent to fish 
farmer/processing 
plant
Results reported to 
Department  and to 
EC (subsequent year 
to sampling) If non-
compliant:
Further 
investigations
Complimentary 
reports sent to fish 
farmer/processing plant 
(subsequent year to 
sampling)
RESIDUES SAMPLING 
LIFE CYCLE
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Figure 7: Locations of sites sampled as part of the residue programme in 2012. 1:3,157,319  
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Figure 8: Locations of sites sampled as part of the residue programme in 2013. 1:3,157,319  
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Figure 9: Locations of sites sampled as part of the residue programme in 2014. 1:3,157,319 
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Samples were taken throughout the year in an effort to spread sampling across 
different sites and are taken in accordance with the National Residue Plan i.e. 
 
 Harvest: Two thirds of the samples are taken at harvest stage which is aimed at 
ensuring compliance with the MRLs and for detection of illegal treatment 
(prohibited substances Group A and unauthorised substances Group B). These 
harvest samples are taken primarily at processing plants (Table 6) for salmon and 
sea reared trout, and ‘on farm’ for freshwater trout. 
 
Table 6: 2012-2014 Active processing plants for salmon and sea reared trout 
 
Eany Fish Products Ltd* 
Irish Seafood Producers Group (ISPG) 
Marine Harvest Ireland Ltd. 
Murphy’s Irish Seafood Ltd. 
Ocean Farm Ltd. 
*Closed June 2013 
 
 
 Other Stages of Production (OSOP): One third of the samples are taken ‘on 
farm’ at the smolt stage (Table 7) prior to going to sea for salmon and at OSOP for 
freshwater trout. This is aimed at detection of illegal treatment (prohibited 
substances/Group A and unauthorised substances /Group B3 (e)-Dyes).  
 
Table 7: Autumn or spring smolts 
 
 
 
 
 
 
 
Spring smolts Autumn smolts  
S1’s : 
Smolts introduced to the sea in March 
S0’s:  
Smolts introduced to the sea in November    
Details:   
 life cycle of the salmon when it changes 
from being a freshwater fish to a seawater 
fish. This process is known as 
smoltification. 
 fish are transported to the saltwater 
environment in the spring, which is 
approximately 15 months after hatching. 
Details:   
 also known as S1/2 
 fish are exposed to manipulated 
photoperiods to hasten the onset of 
smoltification. Hence an S0 smolt is ready 
to go to sea during the Autumn/Winter, 
approximately 11 months after hatching.  
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Figure 10: Life cycle of Irish Atlantic Salmon (Marine Institute, 2015) 
 
Detailed below is a summary of the sampling activities for the period 2012 to 2014. 
See maps in figures 7-9 and appendix 4 for full list of sampling sites. 
 
 
 
2012:  
In 2012, a total of 169 target (surveillance) samples were collected from fish farms and 
processing plants in accordance with the NRCP for Aquaculture 2012 (Appendix 3) as 
follows: 
 
 57 target samples were taken at OSOP; 49 salmon smolts and 8 freshwater 
trout from twelve farms, for Group A and malachite green analysis.  
 112 target samples were taken at harvest which comprised of 89 farmed 
salmon, 15 sea reared trout and 8 freshwater trout. These harvest samples 
were collected during 23 sampling events (samples collected from a given 
site at a given time) throughout the year.  Salmon were collected on 
eighteen occasions, freshwater trout twice and sea reared trout three 
times.  Samples were collected from the same producers on a number of 
occasions due to the small number of active harvest sites in the given year.   
 
2013: 
In 2013, a total of 137 target (surveillance) samples were collected from fish farms and 
processing plants in accordance with the NRCP for Aquaculture 2013 (Appendix 3) as 
follows: 
 
 46 target samples were taken at OSOP; 38 salmon smolts and 8 freshwater 
trout from ten farms, for Group A and malachite green analysis.  
 91 target samples taken at harvest which comprised of 78 farmed salmon, 5 
sea reared trout and 8 freshwater trout. These harvest samples were 
collected during 19 sampling events (samples collected from a given site at a 
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given time) throughout the year.  Salmon were collected on sixteen 
occasions, freshwater trout twice and sea reared trout once.  Samples were 
collected from the same producers on a number of occasions due to the 
small number of active harvest sites in the given year.  
 
2014: 
In 2014, a total of 136 target (surveillance) samples were collected from fish farms and 
processing plants in accordance with the NRCP for Aquaculture 2014 (Appendix 3) as 
follows: 
 
 45 target samples were taken at OSOP; 37 salmon smolts and 8 freshwater trout 
from ten farms, for Group A and malachite green analysis.  
 91 target samples taken at harvest which comprised of 78 farmed salmon, 5 sea 
reared trout and 8 freshwater trout. These harvest samples were collected during 
19 sampling events (samples collected from a given site at a given time) 
throughout the year.  Salmon were collected on sixteen occasions, freshwater 
trout twice and sea reared trout once.  Samples were collected from the same 
producers on a number of occasions due to the small number of active harvest 
sites in the given year.  
 
In 2014, during the first quarter of the year there was limited processing of harvest 
samples, therefore no harvest samples were taken in January and harvest sampling was 
confined to two fish farms for February, March and April.  
 
Suspect Sampling: 
No suspect sampling took place during the period 2012 to 2014 as there was no 
requirement for this arising from surveillance monitoring findings. 
 
 
4.2 RESIDUE ANALYSIS, QUALITY SYSTEM & NRL 
 
4.2.1 Residue Analysis 
 
Prior to testing for a broad range of substances (Table 8), preparation of the samples is 
carried out upon arrival in the laboratory (Fig. 9),  
 
 
On return to the Marine Institute, the 
integrity of the samples is checked to 
ensure chain of custody has been 
maintained. Samples are filleted, scored 
& homogenised.  (Note: Archive 
sample is set aside and stored. This can 
be used where dispute over results 
occurs).The homogenised sample is 
sub- divided into several jars & stored 
in a locked freezer until analysis. The 
chain of custody remains intact from 
farm to final end of year report. 
 
Figure 11: Sample preparation for NRCP samples 
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Table 8: List of analytical methods used for each substances in 2014 Residue Plan for farmed 
finfish 
Group Substance Laboratory 
method 
Group Substance Laboratory 
method 
A3 Steroids:  
Methyltestosterone 
17 ß-Oestradiol 
 
 
ELISA 
ELISA 
 
B2f Other 
pharmacologically 
active substances: 
Teflubenzuron 
Diflubenzuron 
 
 
Corticosteroids 
 
 
 
LC 
 
 
 
ELISA 
A6 Compounds included 
in Annex IV of 
Council Regulation 
2377/90/EC: 
Chloramphenicol 
Nitrofurans  
Nitroimidazoles  
 
 
 
 
ELISA 
LCMSMS 
LCMSMS 
B3a Organochlorine 
compounds: 
PCBs 
OCPs 
 
 
GCHRMS 
B1 Antimicrobials 
(Antibacterial): 
Quinolones 
Tetracyclines 
Florfenicol 
 
Sulphonamides 
 
 
2-plate 
 
 
 
Immunoassay 
B3c Chemical elements: 
Lead 
Cadmium 
Mercury 
 
GFAAS 
GFAAS 
CVAFS 
B2a Anthelmintics 
(Antiparasitic): 
Ivermectin 
Emamectin B1a 
Doramectin* 
 
 
LC 
B3d Mycotoxins: 
Aflatoxin 
 
LC 
B2c Pyrethroids: 
Cypermethrin 
Deltamethrin 
GC B3e Dyes: 
Malachite Green 
Leuco Malachite 
Green 
Crystal Violet 
Leuco Crystal Violet 
Brilliant Green 
Victoria Blue 
 
LCMSMS 
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This testing utilises a variety of modern analytical techniques (Fig. 12) and employs both 
screening and confirmatory techniques. Depending on the parameter, the testing is carried 
out in the Marine Institute laboratories or in approved external laboratories that meet the 
strict validation requirements (Appendix 1 for analytical methodology utilised).  
 
A comprehensive quality assurance programme supports the monitoring programme as 
outlined below 
 
 
 
 
Samples are weighed; homogenised with 
solvent to extract analyte(s) of test; followed 
by sample clean-up techniques such as liquid 
or SPE; analysed by various scientific analytical 
equipment.  
 
 
    
 
Instrumentation used in analysis GC, HPLC, 
LCMSMS 
Figure 12:  Laboratory analysis for NRCP samples 
 
4.2.2 Quality Assurance 
 
Testing as part of the NRCP is carried out in-house in the Marine Institute and also by 
approved subcontracted laboratories. It is a requirement of the NRCP that all screening and 
confirmatory methods are validated to Commission Decision 2002/657/EC2. Commission 
Decision 2002/657/EC specifies the method performance criteria, the validation parameters 
required to demonstrate that an analytical method is fit for ‘purpose’ and the interpretation 
of results for analytical methods that are used for the Residue Directive. To underpin 
provision of high quality monitoring data, all analytical methods used by the Marine Institute 
for the NRCP are accredited to ISO17025. This is the international standard that ensures 
that analytical methods are fit for purpose. The Institute is subject to a range of audits 
including Irish National Accreditation Board (INAB) which is an annual audit against 
ISO17025.  Table 9 lists the NRCP methods which the Marine Institute are accredited by the 
Irish National Accreditation Board (INAB) to ISO 17025 as detailed in Scope Registration 
Number 130T for 2014. Quality Control data for Marine Institute residue analysis in 2012 to 
2014 is reported in Appendix 2.  
                                                 
2  Commission Decision 2002/657/EC establishes criteria and procedures for the validation of analytical methods to ensure 
the quality and comparability of analytical results generated by official laboratories 
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Table 9: Accreditation to ISO17025 
Scope Registration Number 130T 
 Ivermectin, Emamectin B1a , Doramectin                                 (CHE-8)                                                                     
 Mercury                                                                                 (CHE-32) 
 Teflubenzuron , Diflubenzuron                                                (CHE-42) 
 Cadmium                                                                               (CHE-85) 
 Lead                                                                                      (CHE-84) 
 Cypermethrin,   Deltamethrin                                                 (CHE-25) 
 Screening of Antibiotic Residues in Fish                                    (FHU-1) 
 Screening of sulphadiazine                                                       (FHU-119) 
 Dyes: Malachite Green, Crystal Violet, Victoria Blue,                 (CHE-167) 
                     Leuco Crystal Violet, Leuco Malachite Green,  
                     Brilliant Green     
 Moisture %                                                                             (CHE-52)         
Note:  
 When Collecting Samples the Laboratory Complies 
 with Council Directive 96/23/EC                                                       (CHE-6) 
 
4.2.3 NRL 
 
The Marine Institute is the National Reference Laboratory (NRL) for certain substances 
relevant to the NRCP (Table 10). In 2015, the Marine Institute took over the NRL duties 
from Veterinary Public Health Regulatory Laboratory (VPHRL) for chemical elements 
(mercury, lead and cadmium) in aquaculture products.   
 
 
Table 10: Marine Institute National Reference Laboratory (NRL’s) 
Group B (2a) Anthelmentics – Emamectin in Aquaculture only 
Group B (2f) Teflubenzuron & Diflubenzuron in Aquaculture only 
Group B (3e) Malachite Green and Leuco Malachite Green in Aquaculture only 
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4.3 RESULTS OF ANALYSIS 
 
4.3.1 Interpretation of Results  
 
Samples are deemed compliant (i.e. negative) if authorised compounds do not exceed the 
MRL prescribed by the EC in Commission Regulation (EU) No. 37/2010 Table 1  and if 
unauthorised substances are not detected above a defined analytical method decision limit. 
The MRLs and decision limits are specified in Table 11. 
 
Samples are deemed non-compliant (i.e. positive) if concentrations of a given residue are 
confirmed to be present in excess of the MRL, where the MRL has been set. Where no MRL 
is set, (e.g. for banned substances including steroids and compounds listed in Table 2 of 
Commission Regulation (EU) No 37/2010 and for unauthorized substances), a decision limit 
(action level) is used and samples are reported as non-compliant where residues are 
confirmed to be present. 
 
Generally, MRLs will not be exceeded if good husbandry practices are in place and the 
withdrawal periods are adhered to i.e. the animal is not slaughtered for a set period of time 
after treatment.  A non-compliant result (i.e. a confirmed positive result) is assessed and 
reviewed by SFPA and FSAI and an investigation is carried out if required by SFPA with 
Marine Institute assistance.  
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Table 11: Maximum Residues Limits, Decision Limits and Guideline Values used for assessing 
compliance with Residues Directive 
Parameter Maximum Level or 
Decision Limit (6) 
Source 
Group A Compounds1 : 
Methyltestosterone, 17β-Oestradiol, 
Chloramphenicol, Nitrofurans 
&Nitroimidazoles 
These are banned substances and should not be detected. 
Ivermectin 0.4 g kg-1 Decision Limit3 
Doramectin                                                                                                 0.4 g kg-1 Decision Limit3 
Emamectin B1a 100 g kg-1 Maximum Residue Limit2 
Cypermethrin 50 g kg-1 Maximum Residue Limit2 
Deltamethrin 10 g kg-1 Maximum Residue Limit2 
Teflubenzuron 500 g kg-1 Maximum Residue Limit2 
Diflubenzuron 1000 g kg-1 Maximum Residue Limit2 
Antibacterial Substances    
 Sulphonamides 100 g kg-1 Maximum Residue Limit2 
 Oxytetracycline (Tetracyclines) 100 g kg-1 Maximum Residue Limit2 
 Oxolinic Acid (Quinolones) 100 g kg-1 Maximum Residue Limit2 
 Flumequine (Quinolones) 600 g kg-1 Maximum Residue Limit2 
 Sarafloxacin (Quinolones) 30 g kg-1 Maximum Residue Limit2 
 Florfenicol 1000 g kg-1 Maximum Residue Limit2 
ICES PCB 6 7 75 g kg-1 EC Maximum Limit8 
HCB 50 g kg-1 Norway (G)4 
γ HCH 100 g kg-1 Finland (S)4 
p,p’DDT and metabolites 500 g kg-1 Finland (S)4 
Aldrin + Dieldrin 100 g kg-1 Finland (S)4 
Endrin 50 mg kg-1 Finland(S)4 
Malachite Green 0.5 g kg-1 Decision Limit3 
Leuco Malachite Green 0.5 g kg-1 Decision Limit3 
Brilliant Green                                              0.5 g kg-1 Decision Limit3 
Crystal Violet 0.5 g kg-1 Decision Limit3 
Leuco Crystal Violet 0.5 g kg-1 Decision Limit3 
Victoria Blue 0.5 g kg-1 Decision Limit3 
Lead 0.3 mg kg-1 EC Maximum Limit5 
Cadmium 0.05 mg kg-1 EC Maximum Limit5 
Mercury 0.5 mg kg-1 EC Maximum Limit5 
1. Commission Regulation (EU) No 37/2010 (Table 2) and Directive 2008/97/EC: Substances banned and should 
not be detected   
2. Commission Regulation No 37/2010 (Table 1) on pharmacologically active substances and their classification 
regarding maximum residue limits in foodstuffs of animal origin. 
3. These compounds are not authorised for use in finfish, concentrations above the analytical methods 
decision limit are non-compliant. 
4. OSPAR: A compilation of standards and guidance values for contaminants in fish, crustaceans and molluscs for the 
assessment of possible hazards to human health, Update 1993, JMP 17/3/10-E. (S) standard; (G) guidance 
value. 
5. Commission Regulation (EC) No 1881/2006 setting maximum levels for certain contaminant in foodstuffs and its 
amendments Commission Regulation 629/2008/EEC and 565/2008/EEC.   
6. Maximum Residue Limits and Decision Limits concentration are on a wet weight basis. 
7. ICES PCB 6:  sum of the following 6 CB congeners –PCB 28, 52, 101, 138, 153, 180.  
8. Commission Regulation No 1259/2011 amending Regulation No. 1881/2006 as regards maximum levels 
for dioxins, dioxin-like PCBs and non dioxin-like PCBs in foodstuffs. 
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4.3.2 Summary of 2012-2014 results 
 
As in the recent years, no non-compliant results for target samples were reported in the 
national monitoring programme for farmed finfish in 2012-2014.  Outlined below is an overall 
summary:  
 
 2012: in excess of 784 tests and a total of 1,596 residue measurements were carried 
out on 169 samples of farmed finfish for a range of residues: all samples were 
compliant 
 
 2013: in excess of 651 tests and a total of 1,494 residue measurements were carried 
out on 137 samples of farmed finfish for a range of residues: all samples were 
compliant 
 
 2014: in excess of 706 tests and a total of 1,882 residue measurements were carried 
out on 136 samples of farmed finfish for a range of residues: all samples were 
compliant 
 
 
Summary target results from sampling of farmed finfish for residues from 2004 - 2015 are 
outlined in Table 12 and 13. Overall, the outcome for aquaculture remains one of 
consistently low occurrence of residues in farmed finfish, with 100% compliance for 
surveillance monitoring residue results for the period 2006-2015. 
 
Table 12: Summary total target results for residue program for 2005-2009. 
 
 
2005 2006 2007 2008 2009 
 
No. Target samples1 
 
164 
(105, 59) 
 
 
162 
(104, 58) 
 
161 
(103, 58) 
162 
(103, 59) 
146 
(98, 48) 
 
Total Group A2 
 
163/0 
 
 
162/0 
 
 
148/0 
 
144/0 
 
128/0 
 
 
Total Group B2 
 
164/0 
 
 
162/0 
 
161/0 162/0 146/0 
 
Total No. of Results3 
 
2251/2 
 
2207/0 
 
2219/0 
 
2073/0 1750/0 
 
% non -compliant 
results 
0.09 0 0 0 0 
1Target samples (sampled at harvest, sampled at other stages of production) 
2 No. of samples tested/No. of samples non-compliant 
        3Total no. of results as samples taken for Group A and Group B substances are tested for multiple residue categories within each group 
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Table 13: Summary total target results for residue program for 2009-2014 
 
2010 2011 2012 2013 2014 
 
No. Target samples1 141 (92, 49) 
140 
(92, 48) 
169 
(112, 57) 
 
137 
(91, 48) 
 
136 
(91, 45) 
 
Total Group A2 109/0 105/0 101/0 
 
83/0 
 
83/0 
 
Total Group B2 141/0 140/0 169/0 
 
137/0 
 
136/0 
 
Total No. of Results3 1569/0 1566/0 1596/0 
 
1494/0 
 
1882/0 
 
% non -compliant 
results 
0 0 0 0 0 
1Target samples (sampled at harvest, sampled at other stages of production) 
2 No. of samples tested/No. of samples non-compliant 
        3Total no. of results as samples taken for Group A and Group B substances are tested for multiple residue categories within each group 
 
 
4.3.3 Breakdown of 2012-2014 Results 
 
Group A 
 Group A3: Steroids 
Screening for Group A3 was carried out by the Irish Equine Centre (IEC) using an ELISA 
method. This method screens for methyltestosterone and 17β-oestradiol, in addition it 
screens for corticosteroids which were previously classed as A3 and now is re-categorised as 
B2f.  Table 14 gives a breakdown of the number of samples tested for in this category in 
2012, 2013 and 2014.  
 
No non-compliant (i.e. no positive) results were reported for Group A3 samples 
for the period 2012 to 2014. 
 
Although all samples were compliant (i.e. no positive) for Group A3, in 2012 three samples 
of farmed salmon from three separate farms and in 2013 two samples of farmed salmon from 
two separate farms gave a screening reading above the plate cut-off for the Group A3 
compound 17β-oestradiol, when these samples were sent for further quantitative LCMSMS 
screening to the Laboratory of the Government Chemist (LGC) they were found to be 
compliant.  
 
Table 14: Number of samples tested for Group A3  
Year 2012 2013 2014 
Methyltestosterone 56 46 44 
17β-oestradiol 12 10 10 
 
 
 Group A6: Compounds included in Annex IV Council Reg. 2377/90 
Screening for Group A6 was carried out by the Irish Equine Centre (IEC) using an ELISA 
method and Teagasc Food Research Centre (TFRC) by mass spectrometer. The IEC 
method screens for chloramphenicol and the TFRC confirmatory method analyses for 
nitrofurans and nitroimidazole. Table 15 gives a breakdown of the number of samples 
tested for in this category in 2012, 2013 and 2014.  
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No non-compliant (i.e. no positive) results were reported for Group A6 
samples for the period 2012 to 2014. 
 
Table 15: Number of samples tested for Group A6 
Year 2012 2013 2014 
Chloramphenicol 56 46 44 
Nitrofurans* 15 12 12 
Nitroimidazoles** 14 12 12 
* marker metabolites of the nitrofurans; furazolidone, furaltadone, nitrofurantoin and nitrofurazone 
** nitroimidazole metabolites:  dimetridazol, ronidazol, metronidazol, hydroxyl-dimetridazol, hydroxyl-metronidazol 
 
 
Figure 13: SPE clean up technique for analysis 
 
Group B 
Group B substances can be classed as authorised substances, unauthorised substances or 
environmental contaminants.  
 
No non-compliant results were obtained for these compounds for the period 
2012-2014. 
 
 Group B1: Antibacterial Substances 
Antibiotic residues were screened using a qualitative in-house screening method for the 
detection of quinolones, tetracyclines, sulphonamide and florfenicol using a modification of 
the Three Plate Test (TPT). In 2013, the Institute developed and validated an Immunoassay 
qualitative method (Evidence Investigator instrument) for the analysis of sulphonamides 
which could detect to 50 µg kg-1(i.e. detect to half the MRL), during this period the analysis of 
sulphonamides was carried out by a subcontract laboratory. In 2014 the testing for 
sulphonamides was resumed in the Institute and this method obtained INAB accreditation.  
Table 16 gives a breakdown of the number of samples tested for in this category in 2012, 
2013 and 2014.  
 
No non-compliant (i.e. no positive) results were reported for Group B1 samples 
for the period 2012 to 2014. 
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Table 16: Number of samples tested for Group B1 
Year 2012 2013 2014 
Quinolones 
Oxolinic acid 
Flumequine 
112 91 91 
Tetracyclines 
oxytetracycline 
112 91 91 
Sulphonamides 112 15* 91** 
Florfenicol 112 91 91 
*LGC: analysed by UPLC-TOF 
**MI: analysed by Evidence Investigator 
 
 Group B2: Other veterinary drugs 
Group B2 are classed as ‘other veterinary drugs’.  In aquaculture these veterinary drugs are 
generally authorised or unauthorised sea lice treatments. Table 17 gives a breakdown of the 
number of samples tested for in this category in 2012, 2013 and 2014.  
 
No non-compliant (i.e. no positive) results were reported for Group B2 samples 
for the period 2012 to 2014. 
 
Although all samples were compliant in 2014, one sample of freshwater trout gave a 
screening reading above the plate cut-off for corticosteroids, this sample was found to be 
compliant when further quantitative LCMS screening by Laboratory of the Government 
Chemist (LGC) was carried out. 
 
Table 17: Number of samples tested for Group B2  
Year 2012 2013 2014 
B2a Anthelmintics: 
Ivermectin, 
Emamectin B1a 
Doramectin 
 
112 
112 
- 
 
91 
91 
- 
 
91 
91 
91 
B2c Pyrethroids: 
Cypermethrin 
Deltamethrin 
 
51 
86 
 
91 
91 
 
91 
86 
B2f – other veterinary 
drugs: 
Corticosteroids* 
 
 
37 
 
 
33 
 
 
28 
B2f other veterinary 
drugs: 
Teflubenzuron 
Diflubenzuron 
 
 
112 
112 
 
 
91 
91 
 
 
91 
91 
*dexamethasone, flumethasone and betamethasone 
 
 
Group B3: Other substances and environmental contaminants 
 
 Group B3a: Environmental Contaminants Polychlorinated Biphenyls 
(PCBs): 
 
As part of the NRCP, the following six non dioxin-like PCBs (NDL-PCB) are monitored; PCB 
28, 52, 101, 138, 153, and 180. These NDL-PCBs are routinely used as a monitoring indicator 
as they are generally presumed to be the most persistent in fish tissue and comprise about 
half of the amount of total PCB present in feed and food. In the case of NDL-PCBs the 
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maximum level of 75 g kg -1 wet weight has been set for the sum of these six congeners 
(also known asICES PCB 63). None of the samples analysed for the period 2012 to 
2014 exceeded this standard of 75 g kg -1 wet weight and were reported as 
compliant. Table 18 gives a breakdown of the number of samples tested for in this category 
in 2012, 2013 and 2014 and Table 20 details the concentration in samples obtained during 
this period 
 
 Organochlorine pesticides (OCPs): 
Chlorinated pesticides behave similarly to PCBs in the environment and do not have 
maximum concentrations in fish set by the EC. A number of OSPAR contracting countries 
have set levels and Table 11 shows the available standards/guidance values in so far as the 
Marine Institute is aware of these.  All the samples analysed for chlorinated pesticides 
for the period 2012 to 2014 were below these levels and were reported as 
compliant. Table 18 gives a breakdown of the number of samples tested for in this category 
in 2012, 2013 and 2014. 
 
Table 18: Number of samples tested for Group B3a  
Year 2012 2013 2014 
PCBs* 22 19 19 
OCPs* 12 10 10 
*Reference Table 22, 23, 24 for further details 
 
 Group B3b: Chemical elements 
For the period of 2012 to 2014, levels of mercury, cadmium and lead were all very low and 
well below the relevant European maximum limits as described in Table 11and all samples 
were reported as compliant. Table 19 gives a breakdown of the number of samples 
tested for in this category in 2012, 2013 and 2014 and Table 20 details the maximum 
concentration in samples obtained during this period. 
 
Table 19: Number of samples tested for Group B3b  
Year 2012 2013 2014 
Mercury 12 10 10 
Cadmium 12 10 10 
Lead 12 10 10 
 
Table 20: Levels of mercury, cadmium, lead and PCBs during 2012-2014  
Year 
Maximum 
concentration 
Median (Upper 
Bound Mean) Range 
EC Maximum 
Limit n 
mg kg-1 ww 
Mercury 0.07 mg kg-1 0.04 (0.04) <0.02 -0.07 0.5 mg kg-1 32 
Cadmium ND <0.005 (<0.005) <0.005 0.05 mg kg-1 32 
Lead 0.09 mg kg-1 0.05 (<0.05) <0.05 – 0.09 0.3 mg kg-1 32 
µg kg-1 ww 
ICES PCB 63 20.1 µg kg-1 7.59 (7.61) 1.5 -20.1 75 µg kg-1 61 
n: number sampled 
ICES PCB 6: sum of the following 6 non dioxin like PCBS–PCB 28, 52, 101, 138, 153, 180 
 
 Group B3c: Mycotoxins 
A mycotoxin is a toxic by-product of mould growth in feed and can remain as a residue in 
meat tissue. The amount and type of mycotoxin varies with environmental conditions such as 
temperature and humidity. The NRCP for Aquaculture for the period 2012 to 2014 analysed 
for the following mycotoxins: aflatoxin B1, aflatoxin B2, aflatoxin G1 and aflatoxin G2.  
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Aflatoxin B1 is the most common in food and amongst the most potent genotoxic and 
carcinogenic aflatoxins. The highest aflatoxin concentration obtained for the samples analysed 
during this period was in 2014 were a concentration of 0.07 g kg -1 (wet weight) for 
aflatoxin B1 was present, currently there is no maximum limit set for aflatoxins in 
fish. 
 
Table 21: Number of samples tested for Group B3c 
Year 2012 2013 2014 
Aflatoxins 7 6 6 
 
 Group B3d: Dyes 
Malachite Green is a common commercial fabric dye which had been widely used both 
prophylactically and in the treatment of fungal infection of both fish and eggs for over 60 
years. It is also effective against several protozoal infestations, including agents causing 
proliferative kidney disease (PKD) and ichthyophthiriosis (white dot disease). Its use had 
been primarily associated with freshwater farms and hatcheries; therefore over recent years, 
monitoring has been scaled up with freshwater installations particularly targeted. Recent 
results suggest that as a result of increased industry awareness that it is an unauthorised 
substance, supported by monitoring and enforcement, the use of malachite green has ceased 
and all target samples tested for malachite green and its metabolite leuco 
malachite green for the period 2012 to 2014 were found to be compliant i.e. 
negative. 
 
 
In 2014, in addition to testing for malachite green and its metabolite leuco malachite green  a 
new method and was developed and validated to include brilliant green, crystal violet, leuco 
crystal violet and victoria blue. These dyes belong to a group of dyes known as 
triphenylmethane dyes and maybe used illegally in aquaculture as they exhibit antimicrobial 
and antiparasitic properties. There has been no evidence of brilliant green, crystal violet, 
leuco crystal violet or victoria blue being used in aquaculture in Ireland; however these dyes 
have the potential to be used to treat Saprolegnia (fungus) either when present on the fish or 
as a prophylactic treatment to protect fish eggs from infection. These dyes are believed to 
have carcinogenic properties and are not authorised for use in the aquaculture industry.  
 
A minimum required performance level (MRPL) has been set for the sum of malachite green 
and leuco malachite green at 2 g kg -1 and the Marine Institute has set a decision limit of 0.5 
g kg -1 for malachite green and leuco malachite green individually i.e. a sample is deemed 
non-compliant if detected above the decision limit of 0.5 g kg -1. No MRPL has been set for 
brilliant green, crystal violet, leuco crystal violet and victoria blue, however as these dyes are 
unauthorised a decision limit of 0.5 g kg -1 has been set for all dyes. All target samples 
tested  in 2014 for crystal violet and its metabolite leuco crystal violet, brilliant 
green and victoria blue were found to be compliant i.e. negative. 
 
Table 22: Number of samples tested for Group B3d 
Year 2012 2013 2014 
Dyes 86* 79* 69 
*Malachite green and leuco malachite green only 
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Table 23: Summary of 2012 residue monitoring results for target farmed fish samples (salmon and 
trout). All tests performed on muscle tissue 
RESIDUE GROUP 
NUMBER 
EXAMINED Non-Compliant1 
DETECTION LIMIT2 
(µg kg-1) 
Methyltestosterone A3 56 0 1.5 
17β-oestradiol A3 12 0 1.5 
Chloramphenicol A6 56 0 0.25 
Nitrofurans A6 15 0 0.06 
Nitroimidazole A6+B2b 14 0 3.0 
Tetracyclines: 
oxytetracycline 
B1 112 0 50 
Quinolones: 
Oxolinic acid  
Flumequine 
B1 112 0  
75 
150 
Florfenicol B1 112 0 250 
Emamectin B1a B2a 112 0 9.0 
Ivermectin B2a 112 0 0.4 
Cypermethrin B2c 51 0 4.0 
Deltamethrin B2c 86 0 4.0 
Corticosteroids B2f 37 0 1.5 
Teflubenzuron B2f 112 0 80 
Diflubenzuron B2f 112 0 86 
ICES PCB 63 B3a 22 0 - 
Pentachlorobenzene B3a 12 0 0.02 
Hexachlorobenzene  B3a 12 0 0.05 
HCP-cis B3a 12 0 0.02 
HCP-trans B3a 12 0 0.07 
Aldrin B3a 12 0 0.07 
Toxaphene 26 B3a 12 0 0.05 
Toxaphene 50 B3a 12 0 0.09 
Toxaphene 62 B3a 12 0 0.16 
Octachlorstyrene B3a 12 0 0.01 
Dieldrin B3a 12 0 0.02 
Endrin B3a 12 0 0.03 
Mirex B3a 12 0 0.02 
Endosulphane sulphate B3a 12 0 0.05 
Endosulphane- α B3a 12 0 0.07 
Endosulphane-β B3a 12 0 0.05 
Chlordane-cis B3a 12 0 0.01 
Chlordane-trans B3a 12 0 0.01 
Nonachlordane-trans B3a 12 0 0.01 
α-HCH B3a 12 0 0.02 
β-HCH B3a 12 0 0.01 
γ-HCH B3a 12 0 0.02 
σ-HCH B3a 12 0 0.08 
DDD-o,p’ B3a 12 0 0.02 
DDT-o,p’ B3a 12 0 0.02 
DDT-p,p’ B3a 12 0 0.02 
DDE-o,p’ B3a 12 0 0.01 
DDE-p,p’ B3a 12 0 0.01 
DDD-p,p’ B3a 12 0 0.02 
Lead B3c 12 0 8 
Cadmium B3c 12 0 2 
Mercury B3c 12 0 8 
Aflatoxins B3d 7 0 0.1 
Malachite Green B3e 86 0 1.0 
Leuco Malachite Green B3e 86 0 1.0 
1 Action limit reference Appendix 2. 
2 Limit of Detection (LOD) for organochlorine compounds are averages as LOD is sample dependant. 
3 ICES PCB 6:  sum of the following 6 non dioxin like PCBS–PCB 28, 52, 101, 138, 153, 180. Commission Regulation No 
1259/2011 (came into force 1st Jan 2012) amending Regulation No. 1881/2006 setting maximum levels for dioxins, dioxin-like 
PCBs and non dioxin-like PCBs in foodstuffs. 
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Table 24: Summary of 2013 Residue Monitoring Results for Target farmed fish samples (salmon and 
trout). All tests performed on muscle tissue 
RESIDUE GROUP NUMBER EXAMINED Non-Compliant
1 DETECTION LIMIT
2 
(g kg -1) 
Methyltestosterone A3 46 0 1.5 
17β-oestradiol A3 10 0 1.5 
Chloramphenicol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A6 46 0 0.25 
Nitrofurans A6 12 0 0.06 
Nitroimidazole A6+B2b 12 0 3.0 
Tetracyclines: 
oxytetracycline 
B1 91 0 50 
Quinolones:Oxolinic acid 
Flumequine 
B1 91 0 75 
150 
Florfenicol B1 91 0 250 
Sulphonamides B1 15 0 50 
Emamectin B1a B2a 91 0 9.0 
Ivermectin B2a 91 0 0.4 
Cypermethrin B2c 91 0 5 
Deltamethrin B2c 91 0 4 
Corticosteroids B2f 33 0 1.5 
Teflubenzuron B2f 91 0 80 
Diflubenzuron B2f 91 0 86 
ICES PCB 63 B3a 19 0 0.61 
Pentachlorobenzene B3a 10 0 0.02 
Hexachlorobenzene B3a 10 0 0.02 
cis-Heptachlorepoxide B3a 10 0 0.02 
trans-Heptachlorepoxide B3a 10 0 0.06 
Aldrin B3a 10 0 0.06 
Toxaphene 26 B3a 10 0 0.04 
Toxaphene 50 B3a 10 0 0.07 
Toxaphene 62 B3a 10 0 0.15 
Octachlorstyrene B3a 10 0 0.02 
Dieldrin B3a 10 0 0.02 
Endrin B3a 10 0 0.02 
Mirex B3a 10 0 0.02 
Endosulphan  sulphate B3a 10 0 0.12 
α -Endosulphan B3a 10 0 0.11 
β –Endosulphan 
 
 
 
 
B3a 10 0 0.12 
cis- Chlordane (α-chlordane) B3a 10 0 0.02 
trans- Chlordane ( γ-chlordane) B3a 10 0 0.02 
trans-nonachlor B3a 10 0 0.02 
Oxychlordane B3a 10 0 0.02 
α-HCH B3a 10 0 0.02 
β-HCH B3a 10 0 0.02 
γ-HCH (lindane) B3a 10 0 0.02 
δ -HCH B3a 10 0 0.02 
DDD-o,p’ B3a 10 0 0.02 
DDT-o,p’ B3a 10 0 0.02 
DDT-p,p’ B3a 10 0 0.02 
DDE-o,p’ B3a 10 0 0.02 
DDE-p,p’ B3a 10 0 0.02 
DDD-p,p’ B3a 10 0 0.02 
Lead B3c 10 0 8 
Cadmium B3c 10 0 2 
Mercury B3c 10 0 8 
Aflatoxins B3d 6 0 0.01 
Malachite Green B3e 79 0 1.0 
Leuco Malachite Green B3e 79 0 1.0 
1 Action limit reference Appendix 2. 
2 Limit of Detection (LOD) for organochlorine compounds are averages as LOD is sample dependant. 
3 ICES PCB 6:  sum of the following 6 non dioxin like PCBS–PCB 28, 52, 101, 138, 153, 180. Commission Regulation No 1259/2011 (came 
into force 1st Jan 2012) amending Regulation No. 1881/2006 setting maximum levels for dioxins, dioxin-like PCBs and non dioxin-like PCBs in 
foodstuffs. 
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Table 25: Summary of 2014 Residue Monitoring Results for Target farmed fish samples (salmon and 
trout). All tests performed on muscle tissue 
RESIDUE GROUP NUMBER EXAMINED Non-Compliant
1 DETECTION LIMIT
2 
(g kg -1) 
Methyltestosterone A3 44 0 1.5 
17β-oestradiol A3 10 0 1.5 
Chloramphenicol A6 44 0 0.25 
Nitrofurans A6 12 0 0.06 
Nitroimidazole A6 12 0 3.0 
Tetracyclines: 
oxytetracycline 
B1 91 0 50 
Quinolones: 
Oxolinic acid 
Flumequine 
B1 91 0 75 
150 
Florfenicol B1 91 0 250 
Sulphonamides: Sulphadiazine B1 91 0 50 
Emamectin B1a B2a 91 0 9.0 
Ivermectin B2a 91 0 0.4 
Doramectin B2a 91 0 0.4 
Cypermethrin B2c 91 0 5 
Deltamethrin B2c 86 0 4 
Corticosteroids B2f 28 0 1.5 
Teflubenzuron B2f 91 0 80 
Diflubenzuron B2f 91 0 86 
ICES PCB 6 (incl. LOQ) B3a 19 0 0.46 
DDT (o p') B3a 10 0 0.02 
DDE (o p') B3a 10 0 0.02 
DDD (o p') B3a 10 0 0.06 
DDD (p p') B3a 10 0 0.06 
DDE (p p') B3a 10 0 0.02 
DDT (p p') B3a 10 0 0.02 
hexachlorobenzene B3a 10 0 0.08 
a-HCH B3a 10 0 0.04 
b-HCH B3a 10 0 0.04 
g-HCH (lindane) B3a 10 0 0.04 
d -HCH B3a 10 0 0.04 
Pentachlorobenzene B3a 10 0 0.08 
aldrin B3a 10 0 0.02 
dieldrin B3a 10 0 0.03 
endrin B3a 10 0 0.05 
a-endosulfan B3a 10 0 0.08 
b-endosulfan B3a 10 0 0.07 
endosulfan sulfate B3a 10 0 0.02 
Toxaphene 26 B3a 10 0 0.08 
Toxaphene 50 B3a 10 0 0.08 
Toxaphene 62 B3a 10 0 0.17 
heptachlor B3a 10 0 0.02 
mirex B3a 10 0 0.02 
oxychlordane B3a 10 0 0.08 
cis-heptachlorepoxide B3a 10 0 0.03 
trans-heptachlorepoxide B3a 10 0 0.05 
octachlorostyrene B3a 10 0 0.01 
trans-nonachlor B3a 10 0 0.01 
trans-chlordane (g- chlordane) B3a 10 0 0.02 
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Table 25: Summary of 2014 Residue Monitoring Results for Target farmed fish samples (salmon & 
trout) continued 
 
RESIDUE GROUP NUMBER EXAMINED Non-Compliant
1 
DETECTION LIMIT2 
(g kg -1) 
cis-chlordane (a-chlordane) B3a 10 0 0.02 
Lead B3c 10 0 8 
Cadmium B3c 10 0 2 
Mercury B3c 10 0 8 
Aflatoxins B3d 6 0 0.01 
Malachite Green B3e 69 0 0.5 
Leuco Malachite Green B3e 69 0 0.5 
Crystal Violet B3e 69 0 0.5 
Leuco Crystal Violet B3e 69 0 0.5 
Victoria Blue B3e 69 0 0.5 
Brilliant Green B3e 69 0 0.5 
1 Action limit reference Appendix 1. 
2 Limit of Detection (LOD) for organochlorine compounds are averages as LOD is sample dependant. 
3 ICES PCB 6:  sum of the following 6 non dioxin like PCBS–PCB 28, 52, 101, 138, 153, 180. Commission Regulation No 1259/2011 (came 
into force 1st Jan 2012) amending Regulation No. 1881/2006 setting maximum levels for dioxins, dioxin-like PCBs and non dioxin-like PCBs in 
foodstuffs. 
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5.0 CONCLUSION 
  
 
Veterinary treatments, environmental contaminants, unauthorised and banned substances in 
farmed finfish analysed in 2012 to 2014 were found to be 100% compliant with the 
requirements of the Residues Directive. No non-compliant results were detected for 
samples analyses as part of the routine targeted monitoring. This suggests that 
there is continued awareness and improved practices within the industry for the past number 
of years as there have been no non-compliant results for target samples since 2005 i.e. 100% 
compliance for surveillance monitoring residue for the period 2006-2014. It also suggests the 
proper use of medicines and treatments including the observation of extended withdrawal 
periods. 
 
Concentrations of environmental contaminants such as trace metals were low and well 
within EC maximum limits. Contaminant levels for PCBs and OCPs analysed as part of 2012 
to 2014 NRCP for farmed finfish, were within regulatory available limits where such limits 
are set for the protection of consumers.   
 
In order to comply with EU legislation, it is necessary that the monitoring of contaminants 
and veterinary residues in farmed fish continues into the future. In addition to meeting 
legislative requirements, this monitoring programme provides ongoing assurance of 
consumer safety and enables ongoing consumer risk assessments. It also provides data to 
support setting of new and practical standards at international level; and provides factual 
information as a basis for considered response to food safety concerns relating to farmed 
finfish. This programme promotes good practice within the fish farming industry on an 
ongoing basis. 
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LEGISLATION 
 
This section lists some of the main legal instruments concerning the Irish finfish aquaculture 
industry for monitoring of NRCP.  
 
European  
Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and 
residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 
86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. 
 
Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 
96/23/EC establishes criteria and procedures for the validation of analytical methods to 
ensure the quality and comparability of analytical results generated by official laboratories  
 
Commission Decision 2003/181/EC of 13 March 2003 amending Decision 2002/657/EC as 
regards the setting of minimum required performance limits (MRPLs) for certain residues in 
food of animal origin. 
 
Commission Decision 2004/25/EC of 22 December 2003 amending Decision 2002/657/EC as 
regards the setting of minimum required performance limits (MRPLs) for certain residues in 
food of animal origin 
 
Regulation (EC) No. 882/2004 of the European Parliament and the Council of 29 April 2004 
on official controls performed to ensure the verification of compliance with feed and food 
law, animal health and animal welfare rules.  
 
Directive 2008/97/EC of the European Parliament and of the Council of 19 November 2008 
amending Council Directive 96/22/EC concerning the prohibition on the use in stock farming 
of certain substances having a hormonal or thyrostatic action and of beta-agonists 
 
REGULATION (EC) No 470/2009 OF THE EUROPEAN PARLIAMENT AND OF THE 
COUNCIL of 6 May 2009 laying down Community procedures for the establishment of 
residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing 
Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European 
Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament 
and of the Council 
 
COMMISSION REGULATION (EU) No 37/2010 of 22 December 2009 on pharmacologically 
active substances and their classification regarding maximum residue limits in foodstuffs of 
animal origin 
 
COMMISSION REGULATION (EU) No 420/2011 of 29 April 2011 amending Regulation 
(EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs 
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COMMISSION REGULATION (EU) No 594/2012 of 5 July 2012 amending Regulation (EC) 
1881/2006 as regards the maximum levels of the contaminants ochratoxin A, non dioxin-like 
PCBs and melamine in foodstuffs 
 
COMMISSION REGULATION (EU) No 1259/2011 of 2 December 2011 amending 
Regulation (EC) No 1881/2006 as regards maximum levels for dioxins, dioxin-like PCBs and 
non dioxin-like PCBs in foodstuffs 
 
Commission Implementing Decision 2014/745/EU of 27 October 2011 amending Decision 
98/536/EC as regards the list of national reference laboratories  
 
National  
Animal Remedies Act, 1993 (Act No 23 of 1993). 
  
European Communities Animal Remedies Regulations 2007. S.I. 786 of 2007 as amended 
SI12/2009 & SI262/2012 
 
European Communities Control of Animal Remedies and their Residues Regulations 2009. 
S.I. 183 of 2009 as amended SI263/2012 
 
 
USEFUL WEBSITES 
 
 BIM www.bim.ie; http://www.bim.ie/about-the-seafood-industry/ 
 Department of Agriculture, Food and the Marine (Ireland): http://www.agriculture.gov.ie/; 
http://www.agriculture.gov.ie/animalhealthwelfare/veterinarymedicinesresidues/ 
 European Agency for the Evaluation of Medicinal Products: 
http://www.ema.europa.eu/ema; 
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/landing/veterinary_medicines
_regulatory.jsp&mid=WC0b01ac058001ff8a 
 European Commission: http://ec.europa.eu/health/veterinary-use/index_en.htm 
 European Food Safety Authority: www.efsa.eu 
 Food Safety Authority of Ireland: www.fsai.ie; 
http://www.fsai.ie/legislation/food_legislation/veterinary_medicines/monitoring_of_residues.ht
ml 
 Marine Institute http://www.marine.ie/Home/; http://www.marine.ie/Home/site-area/areas-
activity/seafood-safety/residues-monitoring?language=ga 
 Sea Fisheries Protection Authority  http://www.sfpa.ie/ 
 Health Products Regulatory Authority https://www.hpra.ie/ 
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APPENDIX 1: METHODS OF ANALYSIS 
Methods of Analysis 
1.1 Sample Collection and Preparation 
In accordance with the 2014 National Residues Control Plan for Aquaculture under 
Council Directive 96/23/EC, Staff authorised under the Animal Remedies Act 1993, 
collected samples at farms or at processing plants. All samples were transported to the 
laboratory under controlled conditions, while ensuring an unbroken chain of custody. 
Sub-samples were taken for both analytical and archive purposes and all sub-samples 
were stored frozen (<-20C).   
1.2 Dyes Analysis  
Samples were extracted for Dyes analysis with Acetonitrile by shaking in the presence of 
hydroxylamine and magnesium sulphate. The eluant is evaporated to dryness followed by 
reconstitution in a mixture of acetonitrile/water /ascorbic acid solution. This solution is 
centrifuged, filtered and analysed for brilliant green, crystal violet, leuco crystal violet, 
leuco malachite green, malachite green and victoria blue by Fast Liquid Chromatography 
coupled to Mass Spectrometry (UFLC-MS/MS).  
 
1.3 Nitrofuran Analysis 
The analysis of nitrofurans was carried out by Teagasc Food Research Centre (TFRC). 
Tissue bound residues of nitrofurans are hydrolysed with acid and derivatised with 2-
nitrobenzaldehyde. The nitrophenyl derivatives are extracted with ethyl acetate and 
determined by Ultra Performance Liquid Chromatography coupled to Mass 
Spectrometry (UPLC-MS/MS) using deuterated analogues as internal standards for 
quantification. Metabolites of furazolidone, furaltadone, nitrofurantoin and nitrofurazone 
are analysed. 
 
1.4 Screening for Group A Compounds & Group B Cortiscosteroids 
Group A compounds were screened using the Elisa method, this testing was 
subcontracted out to Irish Equine Centre (IEC). This method is qualitative in nature and 
was used to detect residues of 17β-oestradiol, chloramphenicol and methyltesterone. 
Corticosteroids were also screened using this method. 
 
1.5 Nitroimidazoles 
Analysis of nitroimidazoles was carried out by Teagasc Food Research Centre (TFRC). 
Samples are extracted with acetonitrile, water, magnesium sulphate and sodium chloride; 
defatted with n-hexane and concentrated. The residue content is determined by Ultra 
Performance Liquid Chromatography coupled to Mass Spectrometry (UPLC-MS/MS) and 
analysed for dimetridazole and its metabolite, ipronidazole and its metabolite, 
metronidazole and its metabolite, ornidazole and ronidazole. 
 
1.6 Analysis for Cypermethrin and Deltramethrin by Gas Chromatography Electron Capture 
Detection (GC-ECD). 
Approximately 2g of sample was extracted using a hexane/acetone mixture, followed by 
liquid/liquid partition and solid phase extraction techniques. The extract was then 
evaporated to dryness and reconstituted in 2,2,4-trimethylpentane. The analysis was 
carried out using Agilent 7890A Gas Chromatography coupled with electron capture 
detector (GC-ECD) with a Chrompack 15m CpSil 8 column.  
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1.7 Analysis of Ivermectin, Doramectin and Emamectin B1a by Ultra Fast Liquid 
Chromatography (UFLC) with Fluorescence Detection. 
A representative sample (5g) from each fish was homogenised and extracted with 
methanol. The extract was cleaned up by liquid/liquid partition and solid phase 
extraction techniques.  The resultant residue was derivatised and analysed by liquid 
chromatography (UFLC) with fluorescence detection. 
 
1.8 Analysis of Teflubenzuron and Diflubenzuron by Ultra Fast Liquid Chromatography 
(UFLC) with Ultraviolet (UV) Detection. 
This method involves the extraction of approximately 3g of tissue with acetonitrile 
followed by clean up using liquid/liquid partition and silica SPE. Quantification was carried 
out by reverse phase UFLC using an acetonitrile/water mobile phase and UV detection. 
Confirmation and peak purity was evaluated using a photodiode array detector.  
 
1.9 Antimicrobial Screening. 
Antimicrobial screening was carried by the Fish Health Unit (FHU) of the Marine 
Institute, using a modification of the Two Plate Test (TPT). The aim of this method is to 
reveal residues of substances with antibacterial activity by testing the fish tissue using 
agar plates that have been seeded with suitably sensitive bacterial cultures. This method 
is qualitative in nature and was used to detect residues of Quinolones, Tetracyclines, and 
Florfenicol. Analysis of Sulphonamide was carried out by Immunoassay, this method is 
qualitative in nature and tested on the Evidence Investigator instrument. 
 
1.10 Analysis for Polychlorinated Biphenyls (PCBs) and Organochlorine Pesticides (OCPs). 
Analysis for Polycholorinated Biphenyls (PCBs) and Organochlorine Pesticides (OCPs) 
was carried out by a subcontracted laboratory (Eurofins).  Prior to the extraction, 13C-
UL-labeled internal standards were added, followed by an extraction using a solid/lipid 
extraction and clean up by a multicolumn system. Concentration levels were determined 
by (high resolution gas chromatography and high resolution mass spectrometry 
(HRGC/HRMS) using a DB-5 capillary column. 
 
1.11 Determination of Cadmium and Lead using Graphite Furnace Atomic Absorption 
Spectroscopy (GFAAS). 
Concentrated nitric acid (4ml) and hydrogen peroxide (4ml) were added to 
approximately 0.2g freeze-dried tissue. Samples were then digested with the aid of 
microwave (CEM Mars5).  Lead and cadmium concentrations were determined using 
Graphite Furnace Atomic Absorption Spectrometry with Zeeman background 
correction (Varian SpectrAA 220Z).   
 
1.12 Determination of Mercury using Cold Vapour Atomic Fluorescence Spectroscopy 
(CVAFS).  
Concentrated nitric acid (4ml) was added to 0.2g of accurately weighed wet tissue, 
which was then digested in a laboratory microwave oven (CEM Mars5).  Mercury 
concentrations were determined by Cold Vapour Atomic Fluorescence Spectroscopy 
(CV-AFS) using a PSA Merlin Analyser. 
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1.13 Determination of Percentage Moisture Content.  
The moisture content was determined by drying approximately 1g of tissue overnight in 
an oven at 104ºC to constant weight. 
1.14 Analysis for Mycotoxins. 
Analysis of Aflatoxins B1, B2, G1 and G2 was carried out under contract with the LGC 
UK.  The method involved the extraction of about 25g of muscle using dichloromethane 
and the extract was cleaned up on an immunoaffinity column.  The subsequent 
determination of aflatoxins B1, B2, G1 and G2 was achieved using Liquid 
Chromatography with Fluorescence Detection after post column derivatisation. 
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APPENDIX 2: QUALITY CONTROL 
 
To check the quality of the data produced during the 2012-2014 National Surveillance Scheme 
for chemical residues in farmed fish, Quality Control (QC) samples in the form of either 
reagent blanks, replicates, spiked samples or Certified Reference Materials (CRMs) were 
analysed with each batch of samples. The Marine Institute quality assurance results obtained, as 
shown below  1 Standard Deviations (SD), were considered sufficient for the purpose of the 
monitoring programme.  For CRMs, z-scores were calculated using the methodology of 
QUASIMEME (Quality Assurance of Marine Environment and Monitoring in Europe). A Z-
score of between –2 and +2 is generally considered satisfactory for the purpose of 
environmental monitoring programmes. 
 
QC data for 2012 samples   
Analyte QC Type Target 
Value 
Result   SD Mean 
Z – Score 
 Anthelmintics (g kg-1)   
Ivermectin Spike (n=18) 2.0 88.0  5.4% Recovery -- 
Emamectin B1a Spike (n=18) 100 80.0  12.2% Recovery -- 
 Pyrethroids (g kg-1)   
Cypermethrin Spike (n=20) 50 90.6  9.4% Recovery -- 
Deltamethrin Spike (n=16) 10 92.3  9.2% Recovery -- 
 Benzoylurea (g kg-1) 
Teflubenzuron Spike (n=21) 500 87.8  14.3% Recovery -- 
Diflubenzuron Spike (n=21) 1000 89.0  14.8% Recovery -- 
 Malachite Green (g kg-1) 
Malachite Green Spike (n=26) 2 105.8 ± 21.1% Recovery -- 
Leuco Malachite Green Spike (n=26) 2 102.1  19.1% Recovery -- 
 Chemical Elements (mg kg-1)   
Lead SRM 2976 (n=2) 1.19 1.26 0.46 
Cadmium 1566b (n=2) 2.48 2.75  0.85 
Mercury DORM 2 (n=1) 4.64 5.70 1.79 
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QC data for 2013 samples 
  
Analyte QC Type Target Value Result   SD 
Mean 
Z – Score 
 Benzoylurea (g kg-1)   
Teflubenzuron Spike (n=16) 500 89.2  9.3% Recovery -- 
Diflubenzuron Spike (n=16) 1000 84.2 7.2% Recovery -- 
 Pyrethroids (g kg-1)   
Cypermethrin Spike (n=20) 50 81.9  7.9% Recovery -- 
Deltamethrin Spike (n=17) 10 83.9  4.4% Recovery -- 
 Anthelmintics (g kg-1) 
New Instrument 
Ivermectin 
Emamectin B1a 
 
Spike (n=11) 
Spike (n=11) 
 
2 
100 
 
89.8  6.2% Recovery 
83.6  10.3% Recovery 
 
-- 
-- 
Old Instrument 
Ivermectin 
Emamectin B1a 
 
   Spike (n=9) 
Spike (n=10) 
 
2 
100 
 
92.87.3 % Recovery 
88.715.3% Recovery 
 
        -- 
        -- 
 Malachite Green (g kg-1) 
Malachite Green Spike (n=26) 2 97.7  9.1% Recovery -- 
Leuco Malachite Green Spike (n=27) 2 101.3  10.3% Recovery -- 
 Chemical Elements (mg kg-1)   
Lead CE278K(n=2) 2.18 2.28 0.37 
Cadmium CE278K (n=1) 0.336 0.32 -0.35 
Mercury CE278K (n=1) 0.071 0.07 -0.053 
Mercury DORM2 (n=1) 4.64 4.826  0.315 
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QC data for 2014 samples 
  
Analyte QC Type Target Value Result   SD 
Mean 
Z – Score 
 Benzoylurea (g kg-1) 
Teflubenzuron Spike (n=25) 500 86.6  7.4% Recovery -- 
Diflubenzuron Spike (n=27) 1000 80.3  6.2% Recovery -- 
 Pyrethroids (g kg-1)   
Cypermethrin Spike (n=18) 50 82.0  8.0% Recovery -- 
Deltamethrin Spike (n=16) 10 84.9  7.7% Recovery -- 
 Anthelmintics (g kg-1) 
Ivermectin Spike (n=22) 2 87.5  6.7% Recovery -- 
Emamectin B1a 
Doramectin 
Spike (n=22) 
Spike (n=22) 
100 
2 
79.8  7.6% Recovery 
92.7  8.1%Recovery 
-- 
-- 
 Dyes (g kg-1) 
Brilliant Green Spike (n=31) 2 97.8  13.2% Recovery -- 
Crystal Violet 
 
Spike (n=31) 2 99.6  3.4% Recovery -- 
Leuco Crystal Violet 
 
Spike (n=31) 2 100.9  6.8%Recovery -- 
 
Leuco Malachite Green 
 
Spike (n=29) 2 107.613.3% Recovery -- 
 
Malachite Green 
 
Spike (n=31) 2 101.4 7.0% Recovery -- 
 Victoria Blue Spike (n=31) 2 102.811.2% Recovery -- 
 Dry weight 
(%) 
QTMO58BT (n=1) 23.56 102.0 % Recovery 0.16 
 
 Chemical Elements (mg kg-1 dry weight)   
Lead SRM 2976 (n=1) 1.19 124.9% Recovery 1.96 
Cadmium SRM 2976 (n=1) 0.82 117.6% Recovery 1.28 
Mercury DORM2 (n=2) 4.64 113.4% Recovery 1.05 
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APPENDIX 3: 2012, 2013, 2014 PLANS FOR THE MONITORING 
AND DETECTION OF RESIDUES IN AQUACULTURE PRODUCTS 
 
2012 Plan for the Monitoring and Detection of Residues in Aquaculture products 
 
1. National Legislation on use of substances listed in Annex I of Directive 
96/23/EC 
Animal Remedies Act, 1993 (No. 23 of 1993) 
Animal Remedies Regulations, 2007 (SI No. 786 of 2007) 
Control of Animal Remedies and their Residues Regulations 2009(SI No. 183 of 2009) 
 
2. Relevant Departments and their infrastructure 
Dept of Agriculture, Food and the Marine 
Agriculture House 
Kildare Street  
Dublin 2  
 
Sea Fisheries Protection Authority    Marine Institute 
Block B     Rinville 
Clogheen     Oranmore    
 Clonakilty      Co. Galway 
Co. Cork      
 
3. Staff resources to carry out plan 
Authorised Officers will collect all samples.   
 
Group A substances will be performed by the Irish Equine Centre- Kildare, 
Laboratory of the Government Chemist-UK, Ashtown Food Research Centre-Dublin 
and the CRL -Bilthoven 
 
Analyses for Group B substances will be performed within the Marine Institute with 
the exception of what is indicated in the plan.  
 
4. Approved laboratories 
Marine Institute,   Laboratory of the Government Chemist,  
Rinville,    Queens Road, 
Oranmore,   Teddington, 
Co. Galway.    Middlesex, 
TW11 OLY, 
England 
Irish Equine Centre (IEC),   
Johnstown,     
Naas,      
Co. Kildare.     
 
RIKILT-CRL    Eurofins GfA GmbH, 
Laboratory for Residue analysis,  D-48161 Münster, 
NL-3720 BA BILTHOVEN,  Germany 
1 ) Netherland,     
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Ashtown Food Research Centre, Wessling GmbH, 
 Teagasc,     Bochum, 
 Ashtown     Germany 
Dublin 15 
 
5. Additional Information 
 For Group A analysis more than half the samples are ‘on farm’ samples, taken at 
various stages of production, the remainder are samples taken at harvest.
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2013 Plan for the Monitoring and Detection of Residues in Aquaculture products 
 
1. National Legislation on use of substances listed in Annex I of Directive 
96/23/EC 
Animal Remedies Act, 1993 (No. 23 of 1993) 
Animal Remedies Regulations, 2007 (SI No. 786 of 2007) 
Control of Animal Remedies and their Residues Regulations 2009(SI No. 183 of 2009) 
 
2. Relevant Departments and their infrastructure 
Dept of Agriculture, Food and the Marine 
Agriculture House 
Kildare Street  
Dublin 2  
 
Sea Fisheries Protection Authority    Marine Institute 
Block B     Rinville 
Clogheen     Oranmore    
 Clonakilty      Co. Galway 
Co. Cork      
 
3. Staff resources to carry out plan 
Authorised Officers will collect all samples.   
 
Group A substances will be performed by the Irish Equine Centre- Kildare, 
Laboratory of the Government Chemist-UK, Ashtown Food Research Centre-Dublin 
and the CRL -Bilthoven 
 
Analyses for Group B substances will be performed within the Marine Institute with 
the exception of what is indicated in the plan.  
 
4. Approved laboratories 
Marine Institute,   Laboratory of the Government Chemist,  
Rinville,    Queens Road, 
Oranmore,   Teddington, 
Co. Galway.    Middlesex, 
TW11 OLY, 
England 
 
Irish Equine Centre (IEC),   
Johnstown,     
Naas,      
Co. Kildare.     
 
 
RIKILT-CRL    Eurofins GfA GmbH, 
Laboratory for Residue analysis,  D-48161 Münster, 
NL-3720 BA BILTHOVEN,  Germany 
Netherland,     
Marine Environment & Health Series, No. 40, 2015 
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Ashtown Food Research Centre, Wessling GmbH, 
 Teagasc,     Bochum, 
 Ashtown     Germany 
Dublin 15 
 
5. Additional Information 
For Group A analysis more than half the samples are ‘on farm’ samples, taken at 
various stages of production, the remainder are samples taken at harvest.
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2014 Plan for the Monitoring and Detection of Residues in Aquaculture products 
 
1. National Legislation on use of substances listed in Annex I of Directive 
96/23/EC 
Animal Remedies Act, 1993 (No. 23 of 1993) 
Animal Remedies Regulations, 2007 (SI No. 786 of 2007) 
Control of Animal Remedies and their Residues Regulations 2009(SI No. 183 of 2009) 
 
2. Relevant Departments and their infrastructure 
Dept of Agriculture, Food and the Marine 
Agriculture House 
Kildare Street  
Dublin 2  
 
Sea Fisheries Protection Authority    Marine Institute 
Block B      Rinville 
Clogheen      Oranmore    
Clonakilty       Co. Galway 
Co. Cork      
 
3. Staff resources to carry out plan 
Authorised Officers will collect all samples.   
 
Group A substances will be performed by the Irish Equine Centre- Kildare, 
Laboratory of the Government Chemist-UK, Ashtown Food Research Centre-Dublin 
and the CRL -Bilthoven 
 
Analyses for Group B substances will be performed within the Marine Institute with 
the exception of those indicated in the plan.  
 
4. Approved laboratories 
Marine Institute,   Laboratory of the Government Chemist,  
Rinville,    Queens Road, 
Oranmore,   Teddington, 
Co. Galway.    Middlesex, 
TW11 OLY, 
England 
 
Irish Equine Centre (IEC),   
Johnstown,     
Naas,      
Co. Kildare.     
 
 
RIKILT-CRL    Eurofins GfA GmbH, 
Laboratory for Residue analysis,  D-48161 Münster, 
NL-3720 BA BILTHOVEN,  Germany 
Netherland,     
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Ashtown Food Research Centre, Wessling GmbH, 
 Teagasc,     Bochum, 
 Ashtown     Germany 
Dublin 15 
 
5. Additional Information 
 For Group A analysis more than half the samples are ‘on farm’ samples, taken at 
various stages of production, the remainder are samples taken at harvest. 
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LIST OF ACRONYMS 
AFC - Ashtown Food Centre  
CRM’s - Certified Reference Materials  
CVAFS - Cold Vapour Atomic Fluorescence Spectroscopy  
DAFM - Department of Agriculture, Fisheries & the Marine 
DDD - Dichlorodiphenyldichloroethane 
DDE - Dichlorodiphenyldichloroethylene 
DDT - Dichlorodiphenyltrichloroethane 
EC – European Commission 
EEC – European Economic Community 
EFSA – European Food Safety Authority 
ELISA method - Enzyme-Linked ImmunoSorbent Assay 
ESB - Electricity Supply Board 
EU – European Union 
FHU - Fish Health Unit  
FSAI - Food Safety Authority of Ireland 
GC-ECD - Gas Chromatography Electron Capture Detection   
GFAAS - Graphite Furnace Atomic Absorption Spectroscopy  
HBCD - Hexabromocyclododecane 
HCB - Hexachlorobenzene 
HCH - Hexachlorocyclohexane 
HPLC - Performance Liquid Chromatography  
HPRA – Health Products Regulatory Authority 
HRGC - High Resolution Gas Chromatography  
HRMS - High Resolution Mass Spectrometry  
ICES - International Council for Exploration of the Sea 
IEC - Irish Equine Centre 
INAB - Irish National Accreditation Board  
ISO - International Organization for Standardization 
ISPG - Irish Seafood Producers Group  
LCMSMS - Liquid Chromatography with tandem Mass Spectrometry detection 
LGC, UK - Laboratory of the Government Chemist, United Kingdom 
LMG - Leuco Malachite Green  
LOD - Limit of Detection  
MG - Malachite Green  
MH - Marine Harvest Ireland Ltd. 
MRL - Maximum Residue Limit  
NDL-PCB non dioxin-like Polychlorinated Biphenyls 
NRCP - National Residue Control Plan  
NRL - National Reference Laboratory  
OCP’s - Organochlorine pesticides  
OSOP - Other Stages of Production  
OSPAR - OSPAR Commission, protecting and conserving the North-East Atlantic and its resources 
PCB - Polychlorinated Biphenyls 
PDBE - Polybrominated diphenyl ethers 
POP - Persistant organic pollutants 
QC - Quality Control  
QUASIMEME - Quality Assurance of Marine Environment and Monitoring in Europe  
SFPA – Sea Fisheries Protection Authority 
SI - Statutory Instrument 
SPE - Solid Phase Extraction  
TPT - Three Plate Test  
UV - Ultraviolet  
VIs - Veterinary Inspector’s  
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